Downregulation of ABCG2 expression decreases the chemoresistance of glioblastoma cancer stem cells [61], and ABCC3 and ABCC5 have been reported to be expressed higher than the other ABCC subfamily members in glioma [62, 63]. This evidence concerns the gene ABCC3 and central nervous system cancer.